Boehringer Ingelheim announces comprehensive settlement of U.S. Pradaxa ® (dabigatran etexilate) litigation

Boehringer Ingelheim announces comprehensive settlement of U.S. Pradaxa ® (dabigatran etexilate) litigation

Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news